BIIB
$243.51
Biogen
$.13
.05%
Earnings Details
3rd Quarter September 2020
Tweet Share Watch
Summary

Biogen Beats

Biogen (BIIB) reported 3rd Quarter September 2020 earnings of $8.84 per share on revenue of $3.4 billion. The consensus earnings estimate was $8.06 per share on revenue of $3.4 billion. The Earnings Whisper number was $8.40 per share. Revenue fell 6.2% compared to the same quarter a year ago.

Biogen Idec Inc, is a biopharmaceutical company. The Company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.

Results
Reported Earnings
$8.84
Earnings Whisper
$8.40
Consensus Estimate
$8.06
Reported Revenue
$3.38 Bil
Revenue Estimate
$3.38 Bil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release